USA: Emergent BioSolutions Faces Investor Revolt Over Botched Vaccines

In the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading. The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’ request.
USA: Emergent BioSolutions Faces Investor Revolt Over Botched Vaccines USA: Emergent BioSolutions Faces Investor Revolt Over Botched Vaccines Reviewed by Shahid Karimi on July 06, 2021 Rating: 5

No comments:

Powered by Blogger.